TMO vs BIIB
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Biogen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | BIIB |
|---|---|---|
| Price | $700.22 | $253.40 |
| Market cap | $259.44B | $37.46B |
| P/E ratio | 36.9 | 109.7 |
| ROE | 13.38% | 1.87% |
| Profit margin | 14.94% | 3.38% |
| Revenue growth | 9.10% | 10.60% |
| Dividend yield | 0.27% | 0.00% |
| Beta | 0.84 | 0.09 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs BIIB in plain English
- TMO is the bigger company — about 6.9× the market cap of BIIB.
- TMO is cheaper on earnings (P/E 36.9 vs 109.7).
- TMO earns a higher return on equity (13% vs 2%).
- BIIB is growing revenue faster (11% vs 9%).
- TMO pays a dividend (0.27%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
BIIB return calculator
See what $1,000 in Biogen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.